Survival after pancreatectomy for pancreatic adenocarcinoma is not impacted by performance status

American Journal of Surgery

Volumn 204, Issue 5, 2012, Pages 704-708

  Mullinax, John E ^a   Hernandez, Jonathan M ^a   Toomey, Paul ^a   Villadolid, Desiree ^a   Bowers, Carl ^b   Cooper, Jennifer ^b   Rosemurgy, Alexander S ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b TAMPA GENERAL HOSPITAL   (United States)

Author keywords

Adjuvant therapy; Karnofsky Performance Status; Pancreatic cancer; Pancreaticoduodenectomy; Performance status

Indexed keywords

ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL PROTOCOL; CORRELATION ANALYSIS; DISEASE FREE SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FITNESS; FUNCTIONAL STATUS; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); SURVIVAL RATE;

ADENOCARCINOMA; CHEMORADIOTHERAPY, ADJUVANT; DECISION SUPPORT TECHNIQUES; HUMANS; KAPLAN-MEIER ESTIMATE; KARNOFSKY PERFORMANCE STATUS; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; PANCREATECTOMY; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; PROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84868523506     PISSN: 00029610     EISSN: 18791883     Source Type: Journal    
DOI: 10.1016/j.amjsurg.2012.01.016     Document Type: Article

References (17)

1. M.H. Katz, H. Wang, J.B. Fleming Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma Ann Surg Oncol 16 2009 836 847
2. J.M. Hernandez, S.M. Cowgill, S. Al-Saadi CA 19-9 velocity predicts disease-free survival and overall survival after pancreatectomy of curative intent J Gastrointest Surg 13 2009 349 353
3. C.R. Ferrone, M.F. Brennan, M. Gonen Pancreatic adenocarcinoma: the actual 5-year survivors J Gastrointest Surg 12 2008 701 706
4. C.P. Raut, J.F. Tseng, C.C. Sun Impact of resection status on pattern of failure and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma Ann Surg 246 2007 52 60
5. J.F. Tseng, C.P. Raut, J.E. Lee Pancreaticoduodenectomy with vascular resection: margin status and survival duration J Gastrointest Surg 8 2004 935 949
6. K.C. Conlon, D.S. Klimstra, M.F. Brennan Long-term survival after curative resection for pancreatic ductal adenocarcinoma Clinicopathologic analysis of 5-year survivors Ann Surg 223 1996 273 279
7. C.M. Halloran, P. Ghaneh, J.P. Neoptolemos Gene therapy for pancreatic cancer - current and prospective strategies Surg Oncol 9 2000 181 191
8. J.H. Klinkenbijl, J. Jeekel, T. Sahmoud Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC gastrointestinal tract cancer cooperative group Ann Surg 230 1999 776 782
9. V.T. Chang, H.T. Thaler, T.A. Polyak Quality of life and survival: the role of multidimensional symptom assessment Cancer 83 1998 173 179
10. A.Z. Weizer, D. Joshi, S. Daignault Performance status is a predictor of overall survival of elderly patients with muscle invasive bladder cancer J Urol 177 2007 1287 1293
11. J. Peccatori, L. Barkholt, T. Demirer Prognostic factors for survival in patients with advanced renal cell carcinoma undergoing nonmyeloablative allogeneic stem cell transplantation Cancer 104 2005 2099 2103
12. S.S. Hwang, V.T. Chang, J. Cogswell Clinical relevance of fatigue levels in cancer patients at a veterans administration medical center Cancer 94 2002 2481 2489
13. C.M. Burrows, W.C. Mathews, H.G. Colt Predicting survival in patients with recurrent symptomatic malignant pleural effusions: an assessment of the prognostic values of physiologic, morphologic, and quality of life measures of extent of disease Chest 117 2000 73 78
14. S. Krishnan, V. Rana, N.A. Janjan Prognostic factors in patients with unresectable locally advanced pancreatic adenocarcinoma treated with chemoradiation Cancer 107 2006 2589 2596
15. T.A. Aloia, J.E. Lee, J.N. Vauthey Delayed recovery after pancreaticoduodenectomy: a major factor impairing the delivery of adjuvant therapy? J Am Coll Surg 204 2007 347 355
16. R.A. Abrams Adjuvant therapy for pancreatic adenocarcinoma: what have we learned since 1985? Int J Radiat Oncol Biol Phys 56 4 Suppl 2003 3 9
17. M.F. Brennan Adjuvant therapy following resection for pancreatic adenocarcinoma Surg Oncol Clin N Am 13 2004 555 566